Topics

Human medicines European public assessment report (EPAR): Brinavess, vernakalant hydrochloride, Atrial Fibrillation, Date of authorisation: 01/09/2010, Revision: 12, Status: Authorised

12:54 EDT 2 May 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Brinavess, vernakalant hydrochloride, Atrial Fibrillation, Date of authorisation: 01/09/2010, Revision: 12, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Brinavess, vernakalant hydrochloride, Atrial Fibrillation, Date of authorisation: 01/09/2010, Revision: 12, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Brinavess, vernakalant hydrochloride, Atrial Fibrillation, Date of authorisation: 01/09/2010, Revision: 12, Status: Authorised"

Quick Search